Associations of ATF4 gene polymorphisms with schizophrenia in male patients

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 6, 2008, Pages 732-736

  Qu, Mei ^a,b   Tang, Fulei ^a   Wang, Lifang ^a   Yan, Hao ^a   Han, Yonghua ^a   Yan, Jun ^a   Yue, Weihua ^a   Zhang, Dai ^a  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Activating transcription factor 4 (ATF4); Genetic association; Haplotype

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GENOMIC DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE LOCATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ACTIVATING TRANSCRIPTION FACTOR 4; ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 51449086380     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30675     Document Type: Article

References (39)

1. Aleman A, Kahn RS, Selten JP. 2003. Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Arch Gen Psychiatry 60(6):565-571.
2. Bartsch D, Ghirardi M, Skehel PA, Karl KA, Herder SP, Chen M, Bailey CH, Kandel ER. 1995. Aplysia CREB2 represses long-term facilitation: Relief of repression converts transient facilitation into long-term functional and structural change. Cell 83(6):979-992.
3. Berrettini WH. 2000. Susceptibility loci for bipolar disorder: Overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 47(3):245-251.
4. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. 2001. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome lq42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family. Am J Hum Genet 69(2):428-433.
5. Blum BP, Mann JJ. 2002. The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 5(2):159-179.
6. Camargo LM, Collura V, Rain JC, Mizuguchi K, Hermjakob H, Kerrien S, Bonnert TP, Whiting PJ, Brandon NJ. 2007. Disrupted in Schizophrenia 1 Interactome: Evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 12(1):74-86.
7. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, et al. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56(2):162-168.
8. Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, Pavlidis P, Yonan AL, Vronskaya S, Grody MB, Cepeda I, et al. 2003. Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39(4):655-669.
9. Enna SJ, Bowery NG. 2004. GABA(B) receptor alterations as indicators of physiological and pharmacological function. Biochem Pharmacol 68(8):1541-1548.
10. Galletly CA, MacFarlane AS, Clark CR. 2007. Impaired updating of working memory in schizophrenia. Int J Psychophysiol 63:265-274.
11. Guan Z, Giustetto M, Lomvardas S, Kim JH, Miniaci MC, Schwartz JH, Thanos D, Kandel ER. 2002. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111(4):483-493.
12. Hai T, Hartman MG. 2001. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene 273(1):1-11.
13. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, et al. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11(3):619-633.
14. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK. 2004. Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 75(5):862-872.
15. Kakiuchi C, Ishiwata M, Nanko S, Kunugi H, Minabe Y, Nakamura K, Mori N, Fujii K, Yamada K, Yoshikawa T, et al. 2007. Association analysis of ATF4 and ATF5, genes for interacting-proteins of DISC1, in bipolar disorder. Neurosci Lett 417(3):316-321.
16. Leung A, Chue P. 2000. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401:3-38.
17. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part II. Schizophrenia. Am J Hum Genet 73(1):34-48.
18. Mackie S, Millar JK, Porteous DJ. 2007. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 17:95-102.
19. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, Clair DM, Muir WJ, Blackwood DH, et al. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9(9):1415-1423.
20. Millar JK, Christie S, Porteous DJ. 2003. Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem Biophys Res Commun 311(4):1019-1025.
21. Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, et al. 2005. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310(5751):1187-1191.
22. Mizukami K, Sasaki M, Ishikawa M, Iwakiri M, Hidaka S, Shiraishi H, Iritani S. 2000. Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia. Neurosci Lett 283(2):101-104.
23. Morris JA, Kandpal G, Ma L, Austin CP. 2003. DISC1 (Disrupted-In- Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: Regulation and loss of interaction with mutation. Hum Mol Genet 12(13):1591-1608.
24. Mowry BJ, Holmans PA, Pulver AE, Gejman PV, Riley B, Williams NM, Laurent C, Schwab SG, Wildenauer DB, Bauche S, et al. 2004. Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry 9(8):784-795.
25. Mukai J, Liu H, Burt RA, Swor DE, Lai WS, Karayiorgou M, Gogos JA. 2004. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 36(7):725-731.
26. Nehring RB, Horikawa HP, El Far O, Kneussel M, Brandstatter JH, Stamm S, Wischmeyer E, Betz H, Karschin A. 2000. The metabotropic GABAB receptor directly interacts with the activating transcription factor 4. J Biol Chem 275(45):35185-35191.
27. Potash JB, Zandi PP, Willour VL, Lan TH, Huo Y, Avramopoulos D, Shugart YY, MacKinnon DF, Simpson SG, McMahon FJ, et al. 2003. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 160(41:680-686.
28. Qu M, Tang F, Yue W, Ruan Y, Lu T, Liu Z, et al. 2007. Positive association of the Disrupted-in-Schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese han population. Am J Med Genet B Neuropsychiatr Genet 144:266-270.
29. Roberts RC. 2007. Schizophrenia in translation: Disrupted in schizophrenia (DISC1): Integrating clinical and basic findings. Schizophr Bull 33(1):11-15.
30. Shi YY, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2):97-98.
31. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, et al. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6):1296-1302.
32. Silva AJ, Kogan JH, Frankland PW, Kida S. 1998. CREB and memory. Annu Rev Neurosci 21:127-148.
33. Steiger JL, Bandyopadhyay S, Farb DH, Russek SJ. 2004. cAMP response element-binding protein, activating transcription factor-4, and upstream stimulatory factor differentially control hippocampal GABA-BR1a and GABABR1b subunit gene expression through alternative promoters. J Neurosci 24(27):6115-6126.
34. Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A, Muir WJ, Blackwood DH, Porteous DJ. 2005. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 10(7):657-668, 616.
35. Tsuang MT, Stone WS, Faraone SV. 2001. Genes, environment and schizophrenia. Br J Psychiatry Suppl 40:s18-s24.
36. Vernon E, Meyer G, Pickard L, Dev K, Molnar E, Collingridge GL, Henley JM. 2001. GABA(B) receptors couple directly to the transcription factor A TF4. Mol Cell Neurosci 17(4):637-645.
37. White JH, McIllhinney RA, Wise A, Ciruela F, Chan WY, Emson PC, Billinton A, Marshall FH. 2000. The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc Natl Acad Sci USA 97(25):13967-13972.
38. Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Y, Chowdari KV, Cardno AG, Zammit S, Jones LA, et al. 2003. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet 73(6):1355-1367.
39. Yue W, Liu Z, Kang G, Yan J, Tang F, Ruan Y, Zhang J, Zhang D. 2006. Association of G72/G30 polymorphisms with early-onset and male schizophrenia. Neuroreport 17(18):1899-1902.